0A05

Medacta Group S.A.

Stock London Stock Exchange – Stock Market Prices, News & Analysis

Medacta Group est une entreprise suisse spécialisée dans la conception, la fabrication et la commercialisation de dispositifs médicaux innovants pour la chirurgie orthopédique et traumatologique.

£ 1.56
0.76 %

Medacta Group S.A.

£ 1.56
0.76 %
0A05

Medacta Group est une entreprise suisse spécialisée dans la conception, la fabrication et la commercialisation de dispositifs médicaux innovants pour la chirurgie orthopédique et traumatologique.

Price history of Medacta Group S.A.
Price history of Medacta Group S.A.

Performance & Momentum

6 Months 9.72 %
1 Year 18.98 %
3 Years 52.12 %
5 Years 46.37 %

Strategic Analysis

Medacta Group S.A. • 2026

Medacta Group positions itself as a European specialist in innovative medical devices dedicated to orthopedic surgery, combining technological expertise with a quality-focused approach to implants. Its business model is built on differentiation through ongoing innovation and the customization of surgical solutions to meet the specific needs of practitioners and patients.

Strengths
  • Strong specialization in a high-value niche segment: orthopedic and trauma surgery
  • Innovative technology portfolio supporting durable differentiation
  • Track record of sustained growth reflecting the robustness of the business model
Weaknesses
  • Limited exposure to markets outside Europe, which may constrain long-term growth
Momentum

The stock shows robust and sustained momentum supported by strong performance over several years. The absence of recent news may suggest a consolidation phase, but sector dynamics and technological specialization remain favorable factors to maintain a positive valuation bias.

Similar stocks to Medacta Group S.A.

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone